Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

112 lesbian * levels

12th World AIDS Conference

SKeyword

Abstract--

Keyword

Abstract

group of South African lesbians /Men, morals and misinformation 14238
quamous intraepithelial lesion (SIL) in HIV-infected women/Squa 22309
cystic lymphoepithelial (BLL) of the parotid gland is a viral r 32137

uamous intraepithelial lesions
quamous intraepithelial

among HIV positive and HIV-nega 22302
(SIL) in HIV-infected women/Incid 623*/22306

quamous intraepithelial in HIV-infected men/Cost-effectiv
y regression of cervical in HIV-seropositive women receivi
uamous intraepithelial (SIL) and human papiloma virus (
uamous intraepithelial (SILs): Relation with HIV and hum
ation of drug users' skin using photographs: A method for c
es in Kaposi's sarcoma: Phylogenetic and phenetic analys
ed granulomatous skin in a patient with acquired immune
elated multiple organs (ARMOL) with Chinese traditional
nt/Evolution of the skin developed through HIV infection in
diagnosis of CNS mass in patients with AIDS/Use of thalli
V Study/Oral mucosal,CD4 count, viral load and other co
continental Study/Oral and seroconversion - The Triconti
ated Kaposi's sarcoma following treatment with cidofovir/
Pre-malignant cervical (PCL) in HIV+ women in a colposc
n papilloma virus (HPV) in HIV+ and AIDS patients/Human
tis without evident focal: Diagnosis by CSF PCR/Necrops
a rural community in the Lesotho highlands/Sexually transmitted d
omplexes in Indonesia: Lesson learned from the Kramat Tunggak
e prevailing attitudes: A lesson from the field/The challenge is to c

22307
22312
22316
22319
23238
31193
31224
60062
60080
60275
60299
60301
60324
60396
60560
60647
13123
43268
43235
11226
466*/14263
14334
22443
24296
32414
33215
33295
33459
33575
33601
34328
42208
43279
43462
43509

ncy virus-host systems/
Which is actually used?
prevention in Vietnam/
d HIV positive persons/
IV and development:
sed care is impossible:
accine efficacy trials:
mous" about HIV/AIDS:
selling center in Egypt/"
ators in slums of Delhi/
CSWS and their clients:
ity based organisation:
Iment and compliance/
n unrelenting epidemic/
stantly submitted data/
ation in HIV/AIDS work:.......

Lessons learned from comparing pathoge
from the field in a remote district
learned from sexual health traini
and challenges of nutritional hom
learned through partnership/Wo
from an AIDS hospice for ethnic
learned from a US vaccine prepa
learned at the CDC National AID
learned from the establishment o
learnt from the HIV awareness pr
from a 7-year experience/Preve
of the past, visions for the future/
learned in an HIV/AIDS clinical tri
learned from the CDC African-A
learned on trends in HIV/AIDS se
learned for international agencie
I---..-.-. K I-%,r%.. Ir, C% t- I IA.. _, =.146

r/Change in CSF RNA correlates with the effects of maximal 32198
at youth groups: Higher of knowledge and safer behavioural i 33534
nd care at a community /Integration of HIV/AIDS prevention a 374*/34109
nstitutional actions and of commitment as perceived by healt 34166
/Antioxidants enzymes in human blood mononuclear cells fro 42368
dren/Serum y-globulin as a predictor of HIV infection in perin 42399
dren/Serum y-globulin as a predictor of HIV infection in perin 42407
epidemic at community /Using an HIV register to monitor the 43465
atients to health center requires health care reform impleme 43519
ment course for central and mid-level managers/STD progra 43526
uation at the community /Improving HIV/AIDS prevention inter 256*/44302
maker on the gross root /Provision of training and education t 60005
plasmosis/Serum LDH as a clue to the diagnosis of histoplas 60008
Networking at national and strategy development for interve 60101
ampaign among tertiary students in Calabar, Nigeria/An HIV/ 60203
nt increase in viral RNA /Emergence of syncytium-inducing H 60568
adio soap opera/Multi- community participation: Script devel 60802
okines in HIV infection: Levels of MIP-1/ are predictive to the risk 13305
g antiretroviral therapy/ of IL-2 and slL-2R in lymphocyte cu 21191
iated with risk of death/ of specific cytotoxic T-cell (CTL) act 31155
itamin A and E plasma levels in HIV+ ex-homeless subjects living 12121
ostic value of virus load in patients receiving HAART in the F 12129
tion correlate with high of HIV-RNA in cerebral spinal fluid/ 12195
avirdine (DLV) plasma, HIV RNA responses and DLV resist 12206
tion between plasmatic of indinavir and inmunologic and vir 12286
oice strategy/Viral load during treatment with Viracept comb 12300
rapy/Efficacy and drug of ritonavir/saquinavir combination s 12316
erapy/Increases in the of peripheral blood CD34+ CFU-Cs i 12323
ration leads to minimal of proviral DNA and to immune reco 12371
tion to indinavir plasma in HIV-infected patients/Urologic co 12372
omparison of viral load between cohorts infected with HIV-1 13314
pe and CC-chemokine are not significantly different in infec 13380
patients/High prolactin in the cerebrospinal fluid of HIV-infe 21133
me/Increased plasma of soluble adhesion molecules durin 21173
between HIV RNA and of cytokines, chemokines and solubl 21178
m interleukin-16 (IL-16) during the course of HIV-1 infection/ 21187
ssociation with lower of education: A preliminary report/P 22211
rum fluconazole (FLU) with susceptibility testing and clinica 22219
gical efficacy and drug of nelfinavir plus saquinavir as salva 22338
ovudine and two dose of indinavir compared to zidovudine, 22393
ai/HIV-1 subtype RNA in semen of HIV-1 infected Thai men 23395
red to peripheral blood in women with HIV/AIDS/HIV viral I 23477
r and CTL function and of CTL activity are in equilibrium wit 598*/31130
nea-Bissau/lncreased of f-chemokines and antigen specifi 605*/31133
GCV) phosphorylation using vaccinia virus recombinants e 31199
al fluid (CSF) HIV-RNA: Preliminary results/Effect of ritonav 32197
ospinal fluid HIV-1 RNA and efavirenz concentrations in pati 32202
ompliance and plasma in patients treated with indinavir (ID 512*/32330
I treatments (HAART): in the clinical practice and suggestio 32367
valuation of HIV-1 RNA in dried plasma and whole blood spo 33166
on population infection is robustly dependent upon the rate 33257
ly high HIV prevalence /Readiness for HIV counselling and 33261
ry with high prevalence /Critical realities of HIV/AIDS couns 33306
CD30 (sCD30) plasma and the percentage of apoptotic cell 41235
cted mothers/Total IgE in infants born from HIV infected mot 42112
The course of HIV RNA over 17 years of HIV infection in a co 42140
determining HIV-1 RNA present in CDC performance evalua 42142
vicovaginal HIV-1 RNA and plasma viral load/Cervicovagin 42148
y of HIV and HCV RNA in haemophiliacs (Grehco Study)/R 42151
Usefulness of HIV-RNA for monitoring HIV-1 positive individ 42156
y/The roles of HIV RNA and CD4 counts when assessing all 42159
ersus plasma HIV RNA in patients with AIDS-related neurol 42170
d relationship with RNA in plasma/HIV-1 cellular infectious I 42176
mune activation marker compare favorably with and add to v 42181
cal status/Decreasing of anti-Nef antibody correlate with in 42186
onophosphate (dTMP) /Control of zidovudine phosphorylati 42264
e therapy/Low plasma of indinavir (IDV) are highly predictiv 42275
A vaccines/Chemokine modulated in vivo by DNA vaccines/ 42324
e/Increased cobalamin are associated with better cognitive 42359
o initial serum vitamin A /Survival and infections in AIDS pati 42363
mood, coping and CD4 /Effects of self-management trainin 42371
I detectability and CD4 in patients receiving protease inhibit 42403
Kenya: Monitoring HIV and trends/The HIV sentinel surveill 43453
onment/A study on the of physical and verbal harassment o 44179

cytokine and monokine in HIV-1-infected patients with CD4 60132
I ingestion on HIV RNA and CD4 counts in HIV positive subj 60159
ring plasma HIV-1 RNA /The use of NASBA for monitoring pl 60306
ected patients/Plasma of pro-inflammatory cytokines after 60488
9 trial/Serum carnitine in AIDS patients with advanced HIV 60508
grants with low literacy as peer-educators in the Washingto 60531

y of small interventions: learned Dy NGOiu AID Ceii/Mviuti 4429
to AIDS: Programmatic lessons learned/Business responds to Al 13433
ogy transfer: Applying learned from prevention planning 43177
erbaijan: Obstacles and learned/HIV/AIDS response anal 43223
workplace programmes learned at General Motors, Kenya 60085
ears of experience and learned/Education of students at t 60645
formation for the world/ Letra S on Internet: An information for the 34216
to fight AIDS in Mexico/ S is an organizational proposal to fig 60202
gainst AIDS/HIV/Video letters between Africa and Europe against 34118
ctivity/Mutations in the leucine zipper-like heptad repeat sequenc 11121
reated patients/Sterile leucocyturia and reversible impairment of 12379
/Progressive multifocal leucoencephalopathy in AIDS: Evolution 32194
rogressive multifocal (PML) in patients 60963
ogic of sub-clinical hairy leucoplakia /Diagnosis cytopathologic of s 60514
ir-induced urticaria and leukocytoclastic vasculitis; cross-reactivit 60274
progressive multifocal leukoencephalopathy /Quantitation of JC 22266
rogressive multifocal /Analysis of JC viru 22322
/Progressive multifocal (PML) treatment w 562*/32193

rogressive multifocal (PML) in HIV infect
progressive multifocal (PML)/Detection o
progressive multifocal leukoencephalopaty with anti-retroviral tri
ochemical study/Hairy leukoplakia: A clinical, histological, cytolo
s/Sub-clinical oral hairy: Histopathological features/S
mentation/Community level-pre and post-HIV-test counselling m
S prevention education/ Level of risk continuum as a tool in HIV/AI
Methodological issues/ of agreement for last sexual encount
s from Jalisco, Mexico/ knowledge, attitudes and resources
iptional activity and the level of seminal chemokines in the sheddin
ing plasma HIV-1 RNA?/Is cell-associated infectious HIV-1
fferences in HIV-1 RNA in a longitudinal study of HIV-1 seroc
on services at the local /Early intervention demonstration pro
tion/Plasma L-selectin correlates with virus load in pediatric
lication is mainly at the of infection as heat-killed organisms
n analysed at single cell during highly active antiretroviral ther
een HIV viral load, CD4 and cervicovaginal human papilloma
ccess at the population /Prevention of vertical HIV transmissi
sion rate at a population: Italy, 1990-1995/Monitoring the tren
oung adults at the local /Communities at risk - Estimating the
d care at the community /The cost of HIV treatment and care a
rugusers" on a national /Training "test-counselling for drugus

32199
32210
32221
41167
60515
60573
13511
14105
43208
279*/11151
13308
13379
13444
21115
21145
221*/21176
22313
23283
23296
23546
24130
24327